Drug comparisons
Alogliptin vs Vildagliptin
Alogliptin vs Vildagliptin: DPP-4 inhibitors for T2DM. Alogliptin (Nesina) has black box warning unlike Vildagliptin. Compare efficacy, safety, and suitability.
No comparison dimensions are available for this page.
Clinical context
This comparison arises when choosing a DPP-4 inhibitor for type 2 diabetes patients, especially those with cardiovascular risk or needing metformin combinations.
Bottom line
Vildagliptin may be preferable for patients at heart failure risk given Alogliptin's black box warning, though both effectively control blood sugar.
All medication comparisons